Search Results - "Liebana, Belen"
-
1
Pharmacological Profiles of Acute Myeloid Leukemia Treatments in Patient Samples by Automated Flow Cytometry: A Bridge to Individualized Medicine
Published in Clinical lymphoma, myeloma and leukemia (01-08-2014)“…Micro-Abstract We have estimated the pharmacological sensitivity and synergism of 125 individual patient samples for all drugs and combination treatments for…”
Get full text
Journal Article -
2
Personalizing Therapies With Ex Vivo Pharmacological Responses May Uncover The Differences Between IDA-DNR-MIT Among European AML Protocols
Published in Blood (15-11-2013)“…Protocols for acute myeloid leukemia (AML) 1st line patients are centered on the combination of Cytarabine and an anthracycline; Idarubicin (IDA), Daunorubicin…”
Get full text
Journal Article -
3
Population Pharmacological Profiles Of AML Treatments In Patient Samples By Automated Flow Cytometry; A Bridge To Individualized Medicine
Published in Blood (15-11-2013)“…To aid in the identification of effective treatments for individual patients, ex vivo assays for detecting cell death inducible by drugs for hematological…”
Get full text
Journal Article -
4
Pharmacological Profile Of Cytarabine and Idarubicin In Patient Samples (ex vivo) With Newly Diagnosed Acute Myeloid Leukemia Identifies Responders Vs Non Responders
Published in Blood (15-11-2013)“…▪ Complete remission (CR) after induction therapy is the first treatment goal in acute myeloid leukemia (AML) patients. The aim of this study is to determine…”
Get full text
Journal Article -
5